- Home
- VRCA vs CPBI Comparison
VRCA vs CPBI Comparison
Compare VRCA & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- CPBI
- Stock Information
- Founded
- VRCA 2013
- CPBI 2023
- Country
- VRCA United States
- CPBI United States
- Employees
- VRCA N/A
- CPBI N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- CPBI
- Sector
- VRCA Health Care
- CPBI
- Exchange
- VRCA Nasdaq
- CPBI Nasdaq
- Market Cap
- VRCA 58.0M
- CPBI N/A
- IPO Year
- VRCA 2018
- CPBI N/A
- Fundamental
- Price
- VRCA $0.49
- CPBI $14.98
- Analyst Decision
- VRCA Hold
- CPBI
- Analyst Count
- VRCA 5
- CPBI 0
- Target Price
- VRCA $6.00
- CPBI N/A
- AVG Volume (30 Days)
- VRCA 431.6K
- CPBI 10.1K
- Earning Date
- VRCA 05-12-2025
- CPBI 01-01-0001
- Dividend Yield
- VRCA N/A
- CPBI N/A
- EPS Growth
- VRCA N/A
- CPBI 29.70
- EPS
- VRCA N/A
- CPBI 1.62
- Revenue
- VRCA $7,566,000.00
- CPBI $18,546,000.00
- Revenue This Year
- VRCA $127.58
- CPBI N/A
- Revenue Next Year
- VRCA $88.06
- CPBI N/A
- P/E Ratio
- VRCA N/A
- CPBI $9.27
- Revenue Growth
- VRCA 47.66
- CPBI 13.73
- 52 Week Low
- VRCA $0.38
- CPBI $9.96
- 52 Week High
- VRCA $11.41
- CPBI $15.50
- Technical
- Relative Strength Index (RSI)
- VRCA 47.66
- CPBI 57.80
- Support Level
- VRCA $0.45
- CPBI $14.59
- Resistance Level
- VRCA $0.59
- CPBI $14.85
- Average True Range (ATR)
- VRCA 0.08
- CPBI 0.39
- MACD
- VRCA 0.00
- CPBI 0.07
- Stochastic Oscillator
- VRCA 26.74
- CPBI 100.00
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.